Dr. Satish Kumar Bankuru, MD

Dr. Bankuru practices at U.S. Renal Care Colonial Heights Dialysis in Colonial Heights, Virginia.

Dr. Bankuru's NPI, 1750331732, was assigned on May 11, 2006. Dr. Bankuru holds Virginia license 0101236668.

Dr. Bankuru's primary practice is U.S. Renal Care Colonial Heights Dialysis, at 1617 Boulevard, Suite B&C, Colonial Heights, VA 23834 in Colonial Heights City. The practice phone is (804) 520-1627. Dr. Bankuru also practices at US Renal Care Colonial Heights Dialysis, 3601 Blvd, Colonial Heights, VA 23834.

Dr. Bankuru's primary practice is U.S. Renal Care Colonial Heights Dialysis in Colonial Heights, Virginia. Dr. Bankuru is also affiliated with Bon Secours Southside Medical Center. The medical group on file is Colonial Kidneycare Specialists. Dmand AI also links Dr. Bankuru to 4 more hospitals, 4 dialysis centers, 2 group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bankuru practices, 13 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Bankuru's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bankuru is licensed in Virginia.

CMS data shows 2,693 Medicare services from Dr. Bankuru across 10 procedure codes in 2024, for 582 Medicare patients. Medicare paid $302,824 for them.

CMS counts 582 Medicare patients who saw Dr. Bankuru in 2024. The largest group is 75 to 84, with 237 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 4.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bankuru's median patient age at 71, with 53% women.

In 2024, Dr. Bankuru wrote 2,069 Medicare Part D claims for 398 patients. 92% of them were for generic drugs. CMS names the drug for 1,901 of them, across 30 drugs with 11 or more claims each, at $152,442 in total drug cost. In 2023, CMS named 1,389 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 22 out of 100 for Dr. Bankuru for performance year 2024, reported individually. Dr. Bankuru accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 39 general payments to Dr. Bankuru from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Relypsa, Inc. paid the most, $207.